X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-18
MYLAN
Dec-18
JUBILANT LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0393,313-   
Low Rs6001,824-   
Sales per share (Unadj.) Rs482.61,524.7-  
Earnings per share (Unadj.) Rs40.741.4-  
Cash flow per share (Unadj.) Rs67.4326.9-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs262.31,649.4-  
Shares outstanding (eoy) m155.79514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.7 100.8%   
Avg P/E ratio x20.162.0 32.4%  
P/CF ratio (eoy) x12.27.9 154.8%  
Price / Book Value ratio x3.11.6 200.6%  
Dividend payout %7.40-   
Avg Mkt Cap Rs m127,6701,321,549 9.7%   
No. of employees `0002.435.0 7.0%   
Total wages/salary Rs m15,5590-   
Avg. sales/employee Rs Th30,861.422,412.4 137.7%   
Avg. wages/employee Rs Th6,387.00-   
Avg. net profit/employee Rs Th2,604.4608.6 427.9%   
INCOME DATA
Net Sales Rs m75,178784,435 9.6%  
Other income Rs m4000-   
Total revenues Rs m75,579784,435 9.6%   
Gross profit Rs m15,184202,983 7.5%  
Depreciation Rs m4,151146,877 2.8%   
Interest Rs m2,84337,729 7.5%   
Profit before tax Rs m8,59118,377 46.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,247-2,924 -76.8%   
Profit after tax Rs m6,34421,301 29.8%  
Gross profit margin %20.225.9 78.1%  
Effective tax rate %26.2-15.9 -164.4%   
Net profit margin %8.42.7 310.8%  
BALANCE SHEET DATA
Current assets Rs m31,898438,028 7.3%   
Current liabilities Rs m20,047319,371 6.3%   
Net working cap to sales %15.815.1 104.2%  
Current ratio x1.61.4 116.0%  
Inventory Days Days6884 80.8%  
Debtors Days Days5593 58.8%  
Net fixed assets Rs m60,715152,167 39.9%   
Share capital Rs m156418 37.3%   
"Free" reserves Rs m40,7100-   
Net worth Rs m40,865848,616 4.8%   
Long term debt Rs m30,478915,928 3.3%   
Total assets Rs m96,1762,276,317 4.2%  
Interest coverage x4.01.5 270.5%   
Debt to equity ratio x0.71.1 69.1%  
Sales to assets ratio x0.80.3 226.8%   
Return on assets %9.62.6 368.4%  
Return on equity %15.52.5 618.5%  
Return on capital %16.03.2 504.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m2,3580-   
CASH FLOW
From Operations Rs m13,032163,006 8.0%  
From Investments Rs m-6,177-84,256 7.3%  
From Financial Activity Rs m-9,011-75,938 11.9%  
Net Cashflow Rs m-2,1231,350 -157.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.61 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Opens Marginally Lower; IT Stocks Under Pressure(09:30 am)

Asian share markets edged near this year's peak while benchmark US treasury yields, and the dollar dropped after the Federal Reserve signaled possible interest rate cuts later this year.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 20, 2019 10:21 AM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS